Form 4: Saba Capital Management Reduces Stake in abrdn Life Sciences Investors
SEC Form 4
Saba Capital Management reports selling shares of abrdn Life Sciences Investors, decreasing their beneficial ownership.
Summary
- Saba Capital Management, L.P. filed a Form 4 indicating changes in their beneficial ownership of abrdn Life Sciences Investors (HQL) stock.
- On May 13, 2025, they disposed of 730 shares at a price of $12.28 per share.
- On May 14, 2025, they disposed of 600 shares at a price of $12.04 per share.
- Following these transactions, Saba Capital Management's indirect beneficial ownership stands at 3,052,687 shares.
- Boaz Weinstein, also associated with Saba Capital Management, is listed as a reporting person.
- The filing indicates that Saba Capital Management is a 10% owner and a director.
Sentiment
Score: 4
Explanation: The sentiment is neutral to slightly negative as a large shareholder is reducing their position. This could indicate a lack of confidence or a shift in investment strategy.
Negatives
- Saba Capital Management reduced its stake in abrdn Life Sciences Investors.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders or significant shareholders of a publicly traded company buy or sell shares. This filing indicates a change in Saba Capital Management's investment in abrdn Life Sciences Investors.
Stakeholder Impact
- The reduction in Saba Capital Management's stake could potentially influence investor sentiment towards abrdn Life Sciences Investors.
Key Dates
| Date | Description |
|---|---|
| 05/13/2025 | Saba Capital Management disposed of 730 shares of HQL at $12.28 per share. |
| 05/14/2025 | Saba Capital Management disposed of 600 shares of HQL at $12.04 per share. |
| 05/15/2025 | Date of signature for the Form 4 filing by Zachary Gindes on behalf of Saba Capital Management and by Boaz Weinstein. |
Keywords
Form 4, Beneficial Ownership, Saba Capital Management, abrdn Life Sciences Investors, HQL, Share Disposal, Stock Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.